Dapiprazole hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C19H27N5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DS9UJN1I0X, chemically known as 5,6,7,8-tetrahydro-3-(2-(4-o-tolyl-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine monohydrochloride but more generally known as dapiprazole hydrochloride, which bears US NIH Compound Identifier 91269. European Medicines Agency schedules Dapiprazole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01554MIG. Most nations, for tariff and trade purposes, schedule dapiprazole hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, DAPIPRAZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dapiprazole hydrochloride bears US NLM identifiers UMLS ID C0770916 and NCI Concept Code C47469. SMILES: CC1CCCCC1N2CCN(CC2)CCC3NNC4N3CCCC4.CL.